Medicina
Departamento
Borja
Ibáñez Cabeza
Publicaciones en las que colabora con Borja Ibáñez Cabeza (109)
2024
-
Apolipoprotein E-ϵ2 and Resistance to Atherosclerosis in Midlife: The PESA Observational Study
Circulation Research, Vol. 134, Núm. 4, pp. 411-424
2023
-
Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis
Diabetes Care, Vol. 46, Núm. 11, pp. 2050-2057
-
Determinants of Progression and Regression of Subclinical Atherosclerosis Over 6 Years
Journal of the American College of Cardiology, Vol. 82, Núm. 22, pp. 2069-2083
-
Early insulin resistance in normoglycemic low-risk individuals is associated with subclinical atherosclerosis
Cardiovascular Diabetology, Vol. 22, Núm. 1
-
Longitudinal interplay between subclinical atherosclerosis, cardiovascular risk factors, and cerebral glucose metabolism in midlife: results from the PESA prospective cohort study
The Lancet Healthy Longevity, Vol. 4, Núm. 9, pp. e487-e498
-
Subclinical atherosclerosis and accelerated epigenetic age mediated by inflammation: a multi-omics study
European heart journal, Vol. 44, Núm. 29, pp. 2698-2709
-
β3 adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE-HF): a double blind, placebo-controlled, randomized clinical trial
European Journal of Heart Failure, Vol. 25, Núm. 3, pp. 373-385
2022
-
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
European heart journal, Vol. 43, Núm. 39, pp. 3826-3924
-
Bone marrow activation in response to metabolic syndrome and early atherosclerosis
European Heart Journal, Vol. 43, Núm. 19, pp. 1809-1828
-
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up
European Heart Journal, Vol. 43, Núm. 11, pp. 1059-1103
-
Effects of a comprehensive lifestyle intervention on cardiovascular health: the TANSNIP-PESA trial
European heart journal, Vol. 43, Núm. 38, pp. 3732-3745
-
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
Cardiovascular research, Vol. 118, Núm. 6, pp. 1385-1412
-
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
European Heart Journal, Vol. 43, Núm. 11, pp. 1033-1058
-
New 3-Dimensional Volumetric Ultrasound Method for Accurate Quantification of Atherosclerotic Plaque Volume
JACC: Cardiovascular Imaging, Vol. 15, Núm. 6, pp. 1124-1135
-
Polypill Strategy in Secondary Cardiovascular Prevention
The New England journal of medicine, Vol. 387, Núm. 11, pp. 967-977
-
Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis
eBioMedicine, Vol. 76
2021
-
2020 Update of the quality indicators for acute myocardial infarction: A position paper of the Association for Acute Cardiovascular Care: The study group for quality indicators from the ACVC and the NSTE-ACS guideline group
European Heart Journal: Acute Cardiovascular Care, Vol. 10, Núm. 2, pp. 224-233
-
A novel circulating microRNA for the detection of acute myocarditis
New England Journal of Medicine, Vol. 384, Núm. 21, pp. 2014-2027
-
Glycated Hemoglobin and Subclinical Atherosclerosis in People Without Diabetes
Journal of the American College of Cardiology, Vol. 77, Núm. 22, pp. 2777-2791
-
Progression of Early Subclinical Atherosclerosis (PESA) Study: JACC Focus Seminar 7/8
Journal of the American College of Cardiology, Vol. 78, Núm. 2, pp. 156-179